AVTX
AVALO THERAP (AVTX)
NASDAQ
$7.53-$4.73 (-38.61%)
Price as of Oct 22, 2026 7:58 PM EDT
  • $657.5M
    Market Cap
  • -22.31%
    1-Year Change
  • Biotechnology
    Industry

Top Holders

Institutional
Mutual Funds
Holder
Ownership %
Shares Held
Change (Shares, %)
Report Date
FMR LLC
9.51%
5.1M
+2.2M (+43.54%)
Jun 30, 2026
BLACKROCK, INC.
8.14%
4.4M
+4.0M (+92.51%)
Jun 30, 2026
ARMISTICE CAPITAL, LLC
7.39%
4.0M
0 (0.00%)
Dec 31, 2022
DEEP TRACK CAPITAL, LP
6.73%
3.6M
+3.6M (+100.00%)
Jun 30, 2026
CALIGAN PARTNERS LP
5.90%
3.2M
+1.5M (+48.32%)
Jun 30, 2026
TCG CROSSOVER MANAGEMENT, LLC
5.63%
3.0M
+2.3M (+75.53%)
Jun 30, 2026
AFFINITY ASSET ADVISORS, LLC
5.41%
2.9M
+1.6M (+53.76%)
Jun 30, 2026

Current Ownership Distribution

  • Institutions317.0M (71.69%)
  • Mutual Funds74.7M (16.90%)
  • Insiders50.4M (11.41%)
  • Other0 (0.00%)

Insider Transactions

  • 11.41% (50.4M)
    Current InsiderOwnership (%, shares)
  • 0
    Number of InsiderBuying (last 12 months)
  • $0.00
    Amount of InsiderBuying (last 12 months)
  • 4
    Number of InsiderSelling (last 12 months)
  • $9.1M
    Amount of InsiderSelling (last 12 months)
Insider Name & Title
Type
Date
Transaction Value
Shares
Share Price
Shares After Transactions
Jain Rita
Award
Sep 30, 2026
$16,247.38
1,322
$12.29
1,322
Philip Ron M
Award
Sep 30, 2026
$13,629.61
1,109
$12.29
1,109
Lind Kevin Robert
Award
Sep 30, 2026
$16,616.08
1,352
$12.29
1,352
Doyle Mittie
Chief Medical Officer
Exempt
Aug 28, 2026
$0.00
679
$0.00
113,734
Doyle Mittie
Chief Medical Officer
Exempt
Aug 28, 2026
$5,459.16
679
$8.04
52,455
Doyle Mittie
Chief Medical Officer
Sell
Aug 28, 2026
$13,580.00
679
$20.00
51,776
Sullivan Christopher Ryan
Chief Financial Officer
Exempt
Aug 18, 2026
$0.00
31,031
$0.00
96,242
Sullivan Christopher Ryan
Chief Financial Officer
Exempt
Aug 18, 2026
$306,586.28
31,031
$9.88
70,931
Sullivan Christopher Ryan
Chief Financial Officer
Sell
Aug 18, 2026
$622,323.60
31,031
$20.05
39,900
Doyle Mittie
Chief Medical Officer
Exempt
Aug 17, 2026
$0.00
1,000
$0.00
123,750
Sullivan Christopher Ryan
Chief Financial Officer
Exempt
Aug 17, 2026
$374,896.60
37,945
$9.88
78,718
Doyle Mittie
Chief Medical Officer
Exempt
Aug 17, 2026
$12,650.00
1,000
$12.65
52,776
Sullivan Christopher Ryan
Chief Financial Officer
Exempt
Aug 17, 2026
$28,414.88
2,876
$9.88
81,594
Doyle Mittie
Chief Medical Officer
Sell
Aug 17, 2026
$20,000.00
1,000
$20.00
51,776
Sullivan Christopher Ryan
Chief Financial Officer
Sell
Aug 17, 2026
$753,333.47
37,945
$19.85
43,649
Sullivan Christopher Ryan
Chief Financial Officer
Sell
Aug 17, 2026
$74,762.18
3,749
$19.94
39,900
Sullivan Christopher Ryan
Chief Financial Officer
Exempt
Aug 17, 2026
$0.00
37,945
$0.00
130,149
Sullivan Christopher Ryan
Chief Financial Officer
Exempt
Aug 17, 2026
$0.00
2,876
$0.00
127,273
Riley Jennifer
Chief Strategy Officer
Sell
Aug 11, 2026
$52,012.25
2,655
$19.59
37,041
Doyle Mittie
Chief Medical Officer
Exempt
Aug 10, 2026
$0.00
679
$0.00
114,413
Doyle Mittie
Chief Medical Officer
Exempt
Aug 10, 2026
$5,459.16
679
$8.04
52,455
Doyle Mittie
Chief Medical Officer
Sell
Aug 10, 2026
$13,580.00
679
$20.00
51,776
Doyle Mittie
Chief Medical Officer
Exempt
Jul 27, 2026
$0.00
1,000
$0.00
124,750
Doyle Mittie
Chief Medical Officer
Exempt
Jul 27, 2026
$12,650.00
1,000
$12.65
52,776
Doyle Mittie
Chief Medical Officer
Sell
Jul 27, 2026
$20,000.00
1,000
$20.00
51,776
Philip Ron M
Award
Jun 30, 2026
$1,037.76
69
$15.04
69
Lind Kevin Robert
Award
Jun 30, 2026
$16,619.20
1,105
$15.04
1,105
Jain Rita
Award
Jun 30, 2026
$16,243.20
1,080
$15.04
1,080
Doyle Mittie
Chief Medical Officer
Exempt
Jun 30, 2026
$0.00
2,875
$0.00
125,750
Doyle Mittie
Chief Medical Officer
Exempt
Jun 30, 2026
$0.00
1,779
$0.00
115,092